Literature DB >> 14604320

Relationship between retinal vein occlusion and axial length.

San-Chang Tsai1, Hsin-Yi Chen, Chiu-Ying Chen.   

Abstract

This study examined whether axial length is a local risk factor for central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). The study group consisted of 40 patients with unilateral CRVO and 77 patients with unilateral BRVO. The control group included 67 individuals who matched the study group patients in age, systemic hypertension, and diabetes mellitus status. The axial lengths of affected and fellow eyes of patients and controls were measured using A-scan ultrasonography. The axial length of affected eyes was statistically significantly shorter than that of unaffected eyes in the BRVO group (p < 0.05) but not in the CRVO group (p = 0.05). There were also statistically significant differences in axial length between control eyes and affected eyes in both the CRVO group (p < 0.05) and BRVO group (p < 0.05). Thus, shorter axial length could be a risk factor for developing CRVO and BRVO. The axial lengths of affected eyes in retinal vein occlusion patients tend to be shorter than those of unaffected eyes, especially in BRVO patients.

Entities:  

Mesh:

Year:  2003        PMID: 14604320     DOI: 10.1016/S1607-551X(09)70490-5

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  2 in total

1.  Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry.

Authors:  Andrea Szigeti; Miklós Schneider; Mónika Ecsedy; Zoltán Zsolt Nagy; Zsuzsanna Récsán
Journal:  BMC Ophthalmol       Date:  2015-04-30       Impact factor: 2.209

2.  Optic disc morphology in unilateral branch retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Andrea Szigeti; Miklós Schneider; Mónika Ecsedy; Zoltán Zs Nagy; Zsuzsanna Récsán
Journal:  BMC Ophthalmol       Date:  2015-12-12       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.